Related Experiment Video

Updated: Sep 28, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Valvular disease: the case for conventional treatment

H Scheld1

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital Münster, Germany. h.h.scheld@thgms.uni-muenster.de

The Thoracic and Cardiovascular Surgeon
|November 29, 2002
PubMed

Insights

Minimally invasive cardiac surgery, particularly for valve repair, remains controversial with low adoption rates. Challenges include patient selection, technical complexity, and cost barriers, preventing wider use.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Techniques
  • Surgical Outcomes

Background:

  • Minimally invasive cardiac surgery (MICS) adoption is limited.
  • Valvular surgery presents unique challenges for MICS.
  • Current trends do not indicate an increase in MICS incidence.

Purpose of the Study:

  • To analyze the current status and challenges of minimally invasive cardiac surgery.
  • To identify barriers to the increased adoption of MICS, especially in valvular procedures.

Main Methods:

  • Review of current literature and clinical practice trends in cardiac surgery.
  • Analysis of factors influencing the adoption of minimally invasive approaches.

Main Results:

  • The overall incidence of MICS remains low.
  • Valvular surgery shows particularly low rates of minimally invasive approaches.
  • Key barriers identified include the lack of ideal patient candidates, significant technical difficulties, and financial constraints.

Conclusions:

  • Minimally invasive cardiac surgery, especially for valvular procedures, faces significant hurdles.
  • Wider adoption requires addressing patient selection, technical challenges, and economic factors.

More Related Videos

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.